Page results
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
This page explains what to do if you think your IBD symptoms have returned and who to contact for support.
-
Update about our hospital on Gray's Inn Road
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
UCLH is accelerating clinical trial delivery so that patients gain access to new treatments sooner. The acceleration is happening through close collaboration between research teams and clinical services.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
Patients recovering from coronavirus have spoken movingly about the physical and emotional legacy of the disease.
-
This page is designed to help parents/carers understand the process and what to expect during their child’s admission to the Paediatric ward.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
File results
-
FOI/2024/0360 - Radiology Information System (RIS) supplier/ contract/ staff details
-
FOI/2024/0361 - Recording RTT waiting times: Planned patients guidance
-
FOI/2024/0363 - Freedom of Information responses available for Mesh requests
-
FOI/2024/0365 - Specialist clinical systems to manage patients and patient clinical notes
-
FOI/2024/0371 - Acute myeloid leukaemia treatment
-
FOI/2024/0373 - Allogeneic stem cell transplants/ ECP (ExtraCorporeal Photopheresis) service
-
FOI/2024/0376 - Advice provided on topical medication for eczema patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0416 - Home dialysis treatment